Radioimmunotherapy

Radioimmunotherapy (RIT) is a form of cancer treatment that combines the use of radiation therapy and immunotherapy. It uses radioactive substances bound to antibodies that are specific to cancer cells. This allows the radiation to be delivered to the cancerous cells without harming the healthy cells nearby. RIT has been shown to be especially effective in treating cancers such as non-Hodgkin lymphoma, leukemia and multiple myeloma, as well as certain types of solid tumors. This treatment also has the potential to reduce the side effects of traditional radiation therapy. Furthermore, RIT provides a personalized approach to cancer treatment, as it allows doctors to tailor the treatment to the individual patient’s needs. This makes it an increasingly attractive option for those seeking alternative treatments.